144 related articles for article (PubMed ID: 24696653)
1. Primary carcinoma of the fallopian tube: a review of a single institution experience of 8 cases.
Nanaiah SP; Rathod PS; Rajkumar NN; Kundargi R; Subbian A; Ramachandra PV; Krishnappa S; Narayan A; Devi UK; Uttamchand BD
ScientificWorldJournal; 2014; 2014():630731. PubMed ID: 24696653
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy.
Kietpeerakool C; Srisomboon J; Phongsaranantakul S; Khunamornpong S; Cheewakriangkrai C; Sribanditmongkol N
J Obstet Gynaecol Res; 2014 Mar; 40(3):806-11. PubMed ID: 24738123
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
Gemignani ML; Hensley ML; Cohen R; Venkatraman E; Saigo PE; Barakat RR
Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel- and platinum-based postoperative chemotherapy for primary fallopian tube carcinoma: a single institution experience.
Papadimitriou CA; Peitsidis P; Bozas G; Grimani I; Vlahos G; Rodolakis A; Lianos E; Bamias A; Lainakis G; Dimopoulos MA
Oncology; 2008; 75(1-2):42-8. PubMed ID: 18728371
[TBL] [Abstract][Full Text] [Related]
5. Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.
Pectasides D; Pectasides E; Papaxoinis G; Andreadis C; Papatsibas G; Fountzilas G; Pliarchopoulou K; Macheras A; Aravantinos G; Economopoulos T
Gynecol Oncol; 2009 Oct; 115(1):97-101. PubMed ID: 19615725
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
7. Outcomes for patients with fallopian tube carcinoma managed with adjuvant chemotherapy following primary surgery: a retrospective university experience.
Leath CA; Numnum TM; Straughn JM; Rocconi RP; Huh WK; Kilgore LC; Partridge EE
Int J Gynecol Cancer; 2007; 17(5):998-1002. PubMed ID: 17367322
[TBL] [Abstract][Full Text] [Related]
8. Unexpected primary fallopian tube carcinoma during gynecological operations: Clinicopathological and prognostic factors analyses of 67 cases.
Sun M; Bao L; Shen H; Ji M; Yao L; Yi X; Jiang W
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):626-632. PubMed ID: 31542083
[TBL] [Abstract][Full Text] [Related]
9. Primary fallopian tube carcinoma: the Queensland experience.
Obermair A; Taylor KH; Janda M; Nicklin JL; Crandon AJ; Perrin L
Int J Gynecol Cancer; 2001; 11(1):69-72. PubMed ID: 11285036
[TBL] [Abstract][Full Text] [Related]
10. [Residual Disease Status after Primary Cytoreductive Surgery in Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Carcinoma and Long-Term Progression-Free Survival].
Otsuka I; Matsuura T
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2547-2551. PubMed ID: 28028263
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer.
Wang Y; Herrstedt J; Havsteen H; DePoint Christensen R; Mirza MR; Lund B; Maenpaa J; Kristensen G
BMC Cancer; 2014 Dec; 14():937. PubMed ID: 25494701
[TBL] [Abstract][Full Text] [Related]
12. Fallopian tube carcinoma.
Nikrui N; Duska LR
Surg Oncol Clin N Am; 1998 Apr; 7(2):363-73. PubMed ID: 9537982
[TBL] [Abstract][Full Text] [Related]
13. Primary fallopian tube carcinoma: clinicopathological analysis of 12 cases.
Ou YC; Huang HY; Huang CC; Changchien CC; Tseng CW; Lin H
Taiwan J Obstet Gynecol; 2011 Jun; 50(2):141-4. PubMed ID: 21791297
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and carboplatin therapy in stage I fallopian tube carcinoma.
Gungor T; Altundag OB; Ustunyurt E; Mollamahmutoglu L
Int J Gynaecol Obstet; 2006 Nov; 95(2):163-4. PubMed ID: 16828094
[No Abstract] [Full Text] [Related]
15. Recurrent metastatic fallopian tube carcinoma in pregnancy.
Adolph A; Le T; Khan K; Biem S
Gynecol Oncol; 2001 Apr; 81(1):110-2. PubMed ID: 11277660
[TBL] [Abstract][Full Text] [Related]
16. Primary fallopian tube cancer: domestic data and up-to-date review.
Horng HC; Teng SW; Huang BS; Sun HD; Yen MS; Wang PH; Tsui KH; Wen KC; Chen YJ; Chuang CM; Chao HT; Chang WH
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):287-92. PubMed ID: 25286779
[TBL] [Abstract][Full Text] [Related]
17. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
18. Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.
Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Ohishi R; Hasegawa K; Goto T; Fujiwara K
Int J Gynecol Cancer; 2012 Jan; 22(1):70-5. PubMed ID: 22146766
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
[TBL] [Abstract][Full Text] [Related]
20. [Early stage fallopian tube carcinoma--diagnosis, staging and treatment].
Ben-Ami I; Halperin R; Herman A; Schneider D
Harefuah; 2004 Nov; 143(11):790-3, 839. PubMed ID: 15603266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
